(1 - 9 from 18
)
Arrowhead earns $10M from Amgen | Madison Wisconsin Business ...
madison.com
“We are thrilled that Amgen has advanced AMG 890 into a phase 1 clinical study,” Arrowhead president and CEO Chris Anzalone said. “Amgen ...
sorted by relevance / date